Adil Ahmed, MD
Hand Surgery · Houston, TXNPI 1124480652
Payments from drug & device makers
What this record shows
This record is dominated by grants: $20,000 of the $29,552 with a category attached, or 67.7%. 23 manufacturers reported payments, led by Acumed LLC at 42.8% of the total. Reporting peaked in 2021 at $20,000 and has fallen 92.5% since, to $1,509 in 2025.
Across 101 payments — averaging $292.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acumed LLC$13K
- Arthrex$12K
- Shoulder Innovations, Inc.$2K
- Stryker$1K
- Axogen$677
- Zimmer Biomet$263
- plus $1K from 17 others
What the payments were for
- Grants$20,00068%
- Travel & lodging$1,9367%
- Food & beverage$6,41522%
- Education$1,2004%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acumed LLC | 8 | $12,651 |
| Arthrex | 4 | $11,548 |
| Shoulder Innovations, Inc. | 4 | $1,837 |
| Stryker | 18 | $1,169 |
| Axogen | 21 | $677 |
| Zimmer Biomet | 14 | $263 |
| Medinc Of Texas | 2 | $209 |
| Next Science LLC | 2 | $190 |
| Smith+Nephew | 2 | $171 |
| Tulavi Therapeutics, Inc. | 1 | $162 |
| Johnson & Johnson | 4 | $147 |
| Vericel Corporation | 5 | $96 |
| Travere Therapeutics, Inc. | 5 | $68 |
| Biocomposites Inc | 1 | $64 |
| Endo Pharmaceuticals Inc. | 1 | $44 |
| ETS Wound Care LLC | 1 | $44 |
| Globus Medical | 1 | $40 |
| Checkpoint Surgical, Inc | 2 | $35 |
| Calliditas Therapeutics US Inc. | 1 | $33 |
| Baxter Healthcare | 1 | $32 |
| FX Shoulder Solutions, Inc | 1 | $26 |
| Ardelyx, Inc. | 1 | $23 |
| Integra Lifesciences Corporation | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OsteoMed$1,876
- InSet System$1,808
- ACUMED$592
- AEQUALIS PERFORM$310
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$270
- ALLAY NERVE CAP - SMALL NERVE SET$162
- INTEGRA$144
- Xperience$122
- BlastX$122
How this compares
$29,552 in reported general payments places this provider in the 85th percentile of 170 hand surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 72 | $281 |
| Ondansetron Hcl | 78 | $274 |
| Tramadol Hcl | 83 | $216 |
| Meloxicam | 56 | $135 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Houston
- Kourosh JafarniaHouston$278K
- Andrea TianHouston$26K
- Kyle WoernerHouston$18K
- Adam SharHouston$16K
- Scott MitchellHouston$12K
- Darshan PatelHouston$12K
- Ashton MansourHouston$11K
- Mark KhorsandiHouston$10K
- James BennettHouston$10K
- Randy LuoHouston$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.